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Abstract
OBJECTIVE: To evaluate the effect on influenza vi-
rus of Jinchai, a capsule made of Traditional Chi-
nese Medicine.
METHODS: Madin-darby canine kidney (MDCK)
cells were infected with the FM1 strain of influenza
virus A (subtype H1N1) in vitro. They were used to
explore how Jinchai affected cell adsorption, cell
membrane fusion, transcription and replication of
the influenza virus. Hemagglutinin (HA) protein, in-
tracellular pH, and influenza virus protein acid (PA)
polymerase subunit were detected with confocal
microscopy and real-time fluorescent quantitative
polymerase chain reaction.
RESULTS: Jinchai significantly reduced the expres-
sion of HA and PA polymerase subunit mRNA in in-
fected MDCK cells. Jinchai also significantly de-
creased intracellular pH in infected cells.
CONCLUSIONS: Jinchai had strong anti-influenza
activity against the influenza virus. It weakened the
ability of the influenza virus to adsorb to cell wall
and fuse with cell membranes in the early infection
stage, and inhibited the transcription and replica-
tion of the virus.
© 2013 JTCM. All rights reserved.
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INTRODUCTON
Jinchai, made of Traditional Chinese Medicine, con-
sists of Jinyinhua (Flos lonicerae), Chaihu (Radix bu-
pleuri), Huangqin (Radix astragali) and Dangshen (Ra-
dix codonopsis), As the most important component in
the capsule, Lonicera japonic contains chlorogenic ac-
id, isochlorogenic acid and hyperin, and therefore plays
an implicit role as an anti-influenza antiviral agent.1
The active ingredients of scutellaria are flavonoids, β-si-
tosterol, benzoic acid and baialinase. A study reported
that scutellaria had effect on inhibiting the propaga-
tion of the influenza virus,2 and a decoction of bupleu-
rum and scutellaria could protect cells against the vi-
rus.3 The main active constituents of Dangshen (Radix
codonopsis) include multiple trace elements such as po-
tassium, copper, chromium and lithium, multiple ami-
no acids and 6 polysaccharides. It could enhance the
immunity and resilience in the experimental mice.4
Serum chemistry analysis revealed that the main active
constituents of Jinchai were baicalin and chlorogenic
acid.5 Our early study showed that Jinchai had a role in
inhibiting viruses, including coronavirus causing
SARS, parainfluenza, respiratory syncytial, herpes sim-
plex types I and II, the 3,7-type adenovirus and oth-
ers.5,6 We used influenza FM1 and PR8 strains to in-
fect normal mice and immunocompromised mice, and
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then Jinchai was administered to them. It was found
that Jinchai had significant effect on lung inflamma-
tion in mice with normal immune function.7,8
An influenza virus enters a host cell through HA's ad-
sorption to the host cell surface, and the transcription
and replication of the virus are accomplished by using
the enzymes, raw materials and energy of the host cell.
After cells are infected, degeneration, necrosis and shed-
ding occur. In the study of assessing the antiviral activi-
ty of Jinchai, the process of the virus adsorption, mem-
brane fusion, transcription and replication were investi-
gated, and HA, influenza virus PA polymerase subunit
and intracellular pH were detected.
MATERIALS ANDMETHODS
Materials
Madin-darby canine kidney (MDCK) cells were ob-
tained from the cell center of peking union medical col-
lege and subcultured in the biological safety laboratory.
Jinchai, a pilot product, was produced by the Prepara-
tion center of the china-japanese friendship hospital
(lot no. 20090922, clinical approval document No.
2007 L 05135). A stock solution of 32 mg/mL was pre-
pared in sterile deionized water and filter-sterilized be-
fore the experiment. The maximum nontoxic concen-
tration was 2 mg/mL.
The FM1 strain of influenza virus (H1N1 subtype)
was purchased from Chinese Center for Disease Con-
trol and Prevention. A routine subpassage in embryo-
nated eggs was performed in the biological safety labo-
ratory. Strains were frozen at -80°C.
Reagents included 10% fetal bovine serum (Hao Yang
Technology, Tianjin, China), high-glucose Dulbecco's
modified Eagle's medium (DMEM; Gibco, New York,
USA), an RNA extraction kit (Invitrogen, Shanghai,
China), chloroform (Beijing Chemical Plant, China),
diethylpyrocarbonate (DEPC; Sigma, New York,
USA), a One Step SYBR RT-PCR Kit (Takara, Shang-
hai, China), the pH sensitive C-SNARF-4 fluorescent
probe (Molecular Probes, USA), primers of GAPDH
and FM1-HA (Invitrogen, Shanghai, China), isopropa-
nol (Huadong Reagent Plant, Tianjin, China) and etha-
nol (Beijing Chemical Plant, China). Instruments in-
cluded the Applied Biosystems 7500 Real-Time PCR
System (ABI, Foster, USA); and a FV1000 Confocal
Laser Scanning Microscope. Six-well plates and 35 mm
dishes were purchased from Met-Tech Industries in the
United States. Krebs-Henseleit (KH) solution was pre-
pared with 117 mmol/L NaCl, 4.7 mmol/L KCl, 2.5
mmol/L CaCl2, 1.2 mmol/L MgCl2, 10 mmol/L
HEPES, 1.2 mmol/L KH2 PO4 and 11.1 mmol/L
glucose.
Methods
Inhibiting the influenza virus adsorption: Monolayer
MDCK cells were incubated for 1 h with different con-
centrations of Jinchai in a humidified atmosphere of
5% CO2 at 37℃. After discarding the supernatant, the
cells were washed with Phosphate Buffer Solution
(PBS). MDCK cells were then infected with FM1 and
incubated for 1h at 37℃ with 5% CO2. The superna-
tant was discarded and the cells washed with PBS. Af-
ter digestion with digestive enzyme (Gibco), cells were
centrifuged and the pellet collected for real-time quan-
titative PCR.
To extract the total cellular mRNA, MDCK cells (a
density of 5×105 cells/mL) were incubated in one milli-
liter TRIzol for 20 min at room temperature. The sus-
pension was then centrifuged at 13 400 ×g for 10 min
at 4℃. The supernatant was mixed gently with 0.2 mL
chloroform for 15 s and incubated at room tempera-
ture for 2-3 min. After centrifugation again at 13 400 ×
g for 15 min at 4℃ , the supernatant was mixed with
0.5 mL isopropanol and incubated at room tempera-
ture for 30 min. The precipitate was collected after a
third centrifugation at 13 400 × g for 10 min at 4℃
and washed with one milliliter 75% ethanol, then cen-
trifuged again at 10 400 ×g for 5 min at 4℃. The RNA
precipitate was dried for 5-10 min, and then dissolved
with 15 μL DEPC water, and immediately stored at
－80℃.
Before the one-step real-time fluorescent RT-PCR reac-
tion was performed, samples were diluted 20 times
with DEPC water. The 20 μL total reaction volume in-
cluded 2 μL of the RNA sample, 16.4 μL of One Step
SYBR GREEN, and 0.8 μL (10 pMol) of each primer.
Duplicate PCR reactions were tested using the follow-
ing amplification protocol: 95℃ for 10 s followed by
40 cycles at 95℃ for 5 s and at 60℃ for 34 s. After the
reaction, a melting curve analysis was performed to
identify the specificity of PCR products. The cycle
threshold (Ct) value of each sample was analyzed by Se-
quence Detection System software.
The A/FM/1/47 sequence was downloaded from the
national center for biotechnology (NCBI)-GenBank.
Sequence analysis and primer design were performed
by using primer premier 5.0 software. The melting
temperature value of primers, GC content and the sta-
bility of the 3' end were determined according to opti-
mized primer principles.
Upstream and downstream primers of influenza HA
virus gene sequence were 5′- GACCAATCCTGT-
CACCTCTGAC-3′ and 5′-GGGCATTTGGA-
CAAACGTCTACG-3′ , respectively. Upstream and
downstream primers of the housekeeping gene GAP-
DH were 5′- GGTGAAGGTCGGTGTGAACG -3′
and 5′- CTCGCTCCTGGAAGATGGTG -3′, respec-
tively.
The relative changes in gene expression were calculated
using the relative quantitative method (2-ΔΔCt). TheΔCt was calculated by subtracting the Ct value of the
GAPDH reference from the Ct values of the gene ex-
pression of interest (sample):ΔCtsample＝Ctsample－CtGAPDH.
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The 2-ΔΔCt value represents the relative fold changes be-
tween the calibrator and every treatment group gene ex-
pression.Changes in the relative content were equal to:
2-ΔΔCt ×100%.
Inhibiting the cell membrane fusion of influenza
virus
Fluorescent probe dilution: the concentrated solution
of fluorescent probe from the manufacturer was dilut-
ed to a one millimolar stock solution with dimethyl
sulfoxide (DMSO) and stored in the dark at -70℃ .
The working solution was diluted to 10 mMol/L with
KH, to be used as an indicator of pH value.
Determination of fluorescent probe stability: MDCK
cells at the log phase of growth were digested with tryp-
sin-ethylenediaminetetracetic acid (EDTA), made into
a single-cell suspension, and seeded into pre-sterilized
dishes at a density of 5×105 cells/mL. After dishes were
covered by a monolayer of cells, the culture solution
was discarded, the cells washed three times with KH,
then one milliliter of 10 mMol Snarf-4/AM fluorescent
probe was added. Cells were incubated in the dark at
37℃ for 60 min and washed three times with KH. Dy-
namic changes in fluorescence intensity in the Snarf-4/
AM-labeled cells at 5 min were observed by confocal la-
ser microscopy.
FM1 infection and administration of Jinchai: MDCK
cells were treated according to the process specified in
2), but after being treated with the fluorescent probe
and washed with KH, cells were infected with one mil-
liliter of prepared 100TCID50 FM1. Simultaneously,
1 or 2 mg/mL of the Jinchai dilutions were added to
the infected cells. All experimental groups included
control group, FM1 control group and Jinchai-treated
groups (with different doses).
Measurement by confocal laser microscopy: cells were
observed with an inverted phase contrast microscope at
an excitation wavelength of 488 nm and dual emission
wavelengths 580 and 640 nm. A one-way scan was per-
formed at 8 µs/pixel, at a zoom ratio of 1∶1.6. The flu-
orescence intensity under the selected view was detect-
ed by scanning once every 6 s with a total scan time of
2000 s. The intracellular pH value was represented as
the fluorescent intensity ratio (640 nm/580 nm). A de-
crease in the ratio indicated that the intracellular pH
value increased, i.e., an increase in alkalinity. Conversely,
an increase in the ratio indicated an increase in acidity.
Data were collected with the Olympus FV1000, and
analyzed with LSM 510 software.
Monolayers of cells were cultured in 6-well plates. Af-
ter 1.5 mL of the influenza strain FM1 was added to
every well, cells were incubated for one hour at 37℃
under 5% CO2. After washed with PBS, Jinchai dilu-
tions (1 or 2 mg/mL) were added. Plates were then in-
cubated at 37℃ under 5% CO2. Both control group
and virus-infected groups were included. Every treat-
ment group consisted of 6 identical wells and the exper-
iment was repeated 3 times. After 48 or 72 h of incuba-
tion, cells were harvested and total cellular RNA was
extracted. Real-time quantitative RT-PCR was carried
out as mentioned above.
The sequences of the upstream and downstream prim-
ers of the polymerase PA subunit gene were 5′-TATTG-
GCAAAGTCGGTAT-3′ and 5′-CAGGTTGTCCCTA-
AGAGC-3′ , respectively. Upstream and downstream
primers of the housekeeping gene GAPDH were:
5′-GGTGAAGGTCGGTGTGAACG-3′ and 5′-CTC-
GCTCCTGGAAGATGGTG-3′, respectively.
Data analysis: one way ANOVA was performed to de-
tect difference between groups.
RESULTS
After normal cells were treated with Jinchai, the fluores-
cence intensity ratio was (2.26±0.11). There was no sig-
nificant difference when compared with control group
(P>0.05, see Figure 1). The expression of HA mRNA
increased significantly in the control group, while ex-
pressions decreased in Jinchai-treated groups. There
were significant differences between the Jinchai-treated
groups at both concentrations (1 and 2 mg/mL) and
the control group (P<0.01), and inhibition rates of the
two Jinchai-treated groups were 99.92% and 99.93%,
respectively.
Intracellular fluorescence intensity was 4.70±0.27 after
MDCK cells were infected with the influenza virus.
Compared with the control group, there was a signifi-
cant difference (P<0.01, see Table 1). Their fluores-
cence intensity was 2.89 ± 0.05 after the infected cells
were treated with Jinchai. Compared with the FM1
group, this was a significant difference (P<0.01).
PA mRNA expression was significantly higher in infect-
ed cells than that in the control group (P<0.01, see Fig-
ure 2). PA expression decreased in both Jinchai-treated
groups, and there was a significant difference between
the treatment groups and the control group (P<0.01).
The 2 mg/mL Jin Chai-treated group showed signifi-
cant greater inhibitory effect than that of the 1 mg/mL
Jin Chai-treated group. Inhibition rates were 95.72%
and 98.88%, respectively.
Figure 1 Expression of HA mRNA in every group
A: control group; B: large dose group; C: medium dose
group; D: small dose group. HA: hemagglutinin; FM1: Influ-
enza A1 virus. An asterisk indicates a significant difference
from FM1 infected cells at P<0.05. Double asterisk indicates
a significant difference from FM1 infected cells at P<0.01 (n=
3, xˉ ±SD).
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DISCUSSION
Jinchai inhibits influenza virus infection by blocking
adsorption of virus to cells. HA protein on the surface
of the influenza virion recognizes glycoprotein on the
host cell membrane, and the virion thus adsorbs to the
cell surface.9 HA plays an important role in the patho-
genicity of influenza viruses.10 Through antigenic drift
and shift, HA and NA proteins at the surface of the in-
fluenza virion enable it further bind to sialic acid re-
ceptors, fuse with the membrane, and thus induce
stronger infectivity.11 Therefore, inhibiting the adsorp-
tion of HA proteins to host cells is an effective way to
prevent viral infection. In the study, we found that Jin-
chai could inhibit infection by blocking the adsorption
of influenza virions to cells. There were two possible
reasons. Firstly, Jinchai contained substances that were
similar to the HA protein in structure, and therefore
competed for the receptors on host cell surface. Second-
ly, some components in Jinchai had antiviral effect by
directly inhibiting the binding of HA to cells.
Jinchai prevents influenza virus HA-induced mem-
brane fusion. When influenza virus adsorbs onto the
cell surface, virus particles are wrapped in the invaginat-
ed cell membrane and the virus particles enter by endo-
cytosis. Upon viral entry, the intracellular pH value de-
creases from neutral to 5.0-6.0 due to the acidulation
of the endoplasm. The HA molecule changes structure
into a fusion peptide to enable itself to insert into the
membrane and then induce membrane fusion. The nu-
cleocapsid of influenza virus particles is subsequently
released. The influenza virus requires an acidic pH for
maximal fusion. Changes in the conformation of influ-
enza virus HA drive membrane fusion process.12-14
In our study, the results showed that the fluorescence
intensity of infected MDCK cells was higher than un-
infected cells, and Jinchai treatment induced a signifi-
cant decrease in the fluorescence intensity of infected
cells. As a result, we speculate that Jinchai prevented
the acidification of the cytoplasm and subsequently
conformational changes of HA, and thereby inhibited
the fusion of influenza virions with cell membrane.
Jinchai attenuates transcription and replication of the
influenza virus. The viral polymerase, consisting of PA,
PB1, and PB2 subunits, is responsible for both tran-
scription and replication of the viral RNA and has es-
sential role in maintaining the life cycle of the virus.
The amino-acid residues of PA and PB1 are highly con-
served and their mutation rate is low,15,16 so RNA poly-
merase is regarded as a potentially important target for
antiviral drug design. It has been found that the PA
subunit is involved in multiple virus activities includ-
ing viral RNA polymerase transcription, endonuclease
activity, protease activity and assembly of virus parti-
cles.17-19 PA is synthesized in the infected cytoplasm,
and then enters the nucleus.17,20-28When the gene expres-
sion of PA is reduced or disappears, polymerase synthe-
sis and viral replication is blocked, resulting in a de-
creased number of virions. Dissemination to surround-
ing tissues and the ability to infect nearby normal cells
is therefore limited.29 In the study Jinchai might have
an antiviral effect by inhibiting the activity of PA sub-
unit of RNA polymerase and thus interfering with the
transcription and replication of the influenza virus.
To explore the mechanism of anti-influenza activity of
Jinchai, we used FM1 to infect MDCK cells and de-
tected changes in intracellular pH value and mRNA ex-
pression of the HA gene. Results showed that Jinchai
had an essential inhibitory role in the adsorption and
membrane fusion of the influenza virus. Intracellular
virus particles are responsible for gene transcription
and the primers are its own encoding RNA-dependent
polymerase complex. When there are enough virus pro-
teins in infected cells, virus replication initiates and
substantial progeny virions are generated. With the
help of NA, progeny virions are released to destroy sur-
rounding tissues and cells. In our study, we found that
Jinchai decreased mRNA expression of PA and inhibit-
ed the transcription and replication of the influenza vi-
rus, reducing its ability to infect surrounding tissues.
In our previous study,30-33 we found that Jinchai re-
lieved the lung inflammation induced by influenza vi-
ruses and chemicals, and had antipyretic and immune
regulatory activities. Jinchai improved membrane lipid
fluidity of infected cells and prevented further infec-
tions, and simultaneously inhibited the release of the
inflammatory factor nitric oxide, which reduced the de-
gree of lung injury. In the study, we also found that Jin-
chai had similar antiviral activities. It inhibited the ad-
Table 1 Fluorescence intensity ratio in MDCK cells
Notes: Control: control group; Jinchai: jinchai treated group;
FM1: FM1 group; Jinchai+FM1: Jinchai+FM1 treated group.
FM1: Influenza A1 virus. Compared to control group, aP<0.01;
compared to FM1 group, bP<0.01.
Group
Control
Jinchai
FM1
Jinchai + FM1
Fluorescence intensity ratio
2.10±0.19
2.26±0.11
4.70±0.27a
2.89±0.05b
Figure 2 Expression of PA polymerase subunit mRNA
PA: protein acid; FM1: Influenza A1 virus. An asterisk indi-
cates a significant difference from FM1 infected cells at P<
0.05. Double asterisk indicates a significant difference from
FM1 infected cells at P<0.01 (n=3, xˉ ±SD).
PA
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sorption and cell membrane fusion of the influenza vi-
rus in the early stage of infection, which not only exert-
ed antiviral activities against the virus but avoided dam-
aging the normal functions of host cells.
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